Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06635824
Title Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)
Acronym ABBIL1TY NSCLC-06
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Genmab
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Ocala Oncology Center P.L. RECRUITING Ocala Florida 34474 United States Details
Norton Cancer Institute RECRUITING Louisville Kentucky 40202 United States Details
Oncology Hematology West RECRUITING Omaha Nebraska 68124 United States Details
Clinical Research Alliance RECRUITING Westbury New York 11590 United States Details
University of Tennessee Medical Center Cancer Institute RECRUITING Knoxville Tennessee 37920 United States Details
Nippon Medical School Hospital RECRUITING Bunkyo-ku Japan Details
NHO Hokkaido Cancer Center RECRUITING Hokkaido Japan Details
Miyagi Cancer Center RECRUITING Natori-shi Japan Details
Okayama University Hospital RECRUITING Okayama Japan Details
Osaka Medical and Pharmaceutical University Hospital RECRUITING Osaka Japan Details
Ajou University Hospital RECRUITING Suwon Gyeonggi-do Korea, Republic of Details
Chungbuk National University Hospital RECRUITING Chungcheongbuk-do Korea, Republic of Details
Keimyung University Dongsan Hospital RECRUITING Daegu Korea, Republic of Details
Asan Medical Center RECRUITING Seoul Korea, Republic of Details
Severance Hospital, Yonsei University Health System RECRUITING Seoul Korea, Republic of Details
Pan American Oncology Trials, LLC RECRUITING San Juan 00935 Puerto Rico Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field